248 related articles for article (PubMed ID: 11348602)
1. The QUinapril Ischemic Event Trial (QUIET): evaluation of chronic ACE inhibitor therapy in patients with ischemic heart disease and preserved left ventricular function.
Pitt B; O'Neill B; Feldman R; Ferrari R; Schwartz L; Mudra H; Bass T; Pepine C; Texter M; Haber H; Uprichard A; Cashin-Hemphill L; Lees RS;
Am J Cardiol; 2001 May; 87(9):1058-63. PubMed ID: 11348602
[TBL] [Abstract][Full Text] [Related]
2. The QUinapril Ischemic Event Trial (QUIET) design and methods: evaluation of chronic ACE inhibitor therapy after coronary artery intervention.
Texter M; Lees RS; Pitt B; Dinsmore RE; Uprichard AC
Cardiovasc Drugs Ther; 1993 Apr; 7(2):273-82. PubMed ID: 8357782
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin-converting enzyme inhibition as antiatherosclerotic therapy: no answer yet. QUIET Investigators. QUinapril Ischemic Event Trial.
Cashin-Hemphill L; Holmvang G; Chan RC; Pitt B; Dinsmore RE; Lees RS
Am J Cardiol; 1999 Jan; 83(1):43-7. PubMed ID: 10073783
[TBL] [Abstract][Full Text] [Related]
4. Effects of quinapril on clinical outcome after coronary artery bypass grafting (The QUO VADIS Study). QUinapril on Vascular Ace and Determinants of Ischemia.
Oosterga M; Voors AA; Pinto YM; Buikema H; Grandjean JG; Kingma JH; Crijns HJ; van Gilst WH
Am J Cardiol; 2001 Mar; 87(5):542-6. PubMed ID: 11230836
[TBL] [Abstract][Full Text] [Related]
5. Baseline clinical and angiographic data in the Quinapril Ischemic Event (QUIET) Trial.
Lees RS; Pitt B; Chan RC; Holmvang G; Dinsmore RE; Campbell LW; Haber HE; Klibaner MI; Cashin-Hemphill L
Am J Cardiol; 1996 Nov; 78(9):1011-6. PubMed ID: 8916480
[TBL] [Abstract][Full Text] [Related]
6. The effect of angiotensin converting enzyme inhibition on myocardial function and blood pressure after coronary artery bypass surgery--a randomised study.
Webb CM; Underwood R; Anagnostopoulos C; Bennett JG; Pepper J; Lincoln C; Collins P
Eur J Cardiothorac Surg; 1998 Jan; 13(1):42-8. PubMed ID: 9504729
[TBL] [Abstract][Full Text] [Related]
7. The Quinapril Ischemic Event Trial (QUIET).
Pitt B
Blood Press Suppl; 1992; 4():11-2. PubMed ID: 1345328
[No Abstract] [Full Text] [Related]
8. Quinapril: a further update of its pharmacology and therapeutic use in cardiovascular disorders.
Culy CR; Jarvis B
Drugs; 2002; 62(2):339-85. PubMed ID: 11817979
[TBL] [Abstract][Full Text] [Related]
9. Rationale for ACE inhibition as an anti-ischaemic therapy.
Pepine CJ
Eur Heart J; 1998 Jul; 19 Suppl G():G34-40. PubMed ID: 9717054
[TBL] [Abstract][Full Text] [Related]
10. Effects of angiotensin-converting enzyme inhibition on transient ischemia: the Quinapril Anti-Ischemia and Symptoms of Angina Reduction (QUASAR) trial.
Pepine CJ; Rouleau JL; Annis K; Ducharme A; Ma P; Lenis J; Davies R; Thadani U; Chaitman B; Haber HE; Freedman SB; Pressler ML; Pitt B;
J Am Coll Cardiol; 2003 Dec; 42(12):2049-59. PubMed ID: 14680725
[TBL] [Abstract][Full Text] [Related]
11. Quinapril with high affinity to tissue angiotensin-converting enzyme reduces restenosis after percutaneous transcatheter coronary intervention.
Okimoto T; Imazu M; Hayashi Y; Gomyo Y; Sekiguchi Y; Yanagihara K; Shimohara Y; Sumii K; Yamamoto H; Tadehara F; Toyofuku M; Kohno N
Cardiovasc Drugs Ther; 2001 Jul; 15(4):323-9. PubMed ID: 11800416
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing ENdothelial Dysfunction) Study.
Mancini GB; Henry GC; Macaya C; O'Neill BJ; Pucillo AL; Carere RG; Wargovich TJ; Mudra H; Lüscher TF; Klibaner MI; Haber HE; Uprichard AC; Pepine CJ; Pitt B
Circulation; 1996 Aug; 94(3):258-65. PubMed ID: 8759064
[TBL] [Abstract][Full Text] [Related]
13. [Does quinapril improve coronary vasoconstriction in vasospastic angina?].
Anzai H; Saijo T; Nakajima R; Tezuka N; Takagi T; Tsunoda T; Kobayashi N; Nakamura S; Yamaguchi T
J Cardiol; 2000 Dec; 36(6):379-86. PubMed ID: 11190581
[TBL] [Abstract][Full Text] [Related]
14. Chronic effects of early started angiotensin converting enzyme inhibition and angiotensin AT1-receptor subtype blockade in rats with myocardial infarction: role of bradykinin.
Hu K; Gaudron P; Anders HJ; Weidemann F; Turschner O; Nahrendorf M; Ertl G
Cardiovasc Res; 1998 Aug; 39(2):401-12. PubMed ID: 9798525
[TBL] [Abstract][Full Text] [Related]
15. Effects of angiotensin-converting enzyme inhibition in low-risk patients early after coronary artery bypass surgery.
Rouleau JL; Warnica WJ; Baillot R; Block PJ; Chocron S; Johnstone D; Myers MG; Calciu CD; Dalle-Ave S; Martineau P; Mormont C; van Gilst WH;
Circulation; 2008 Jan; 117(1):24-31. PubMed ID: 18071079
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin-converting enzyme inhibition in patients with coronary artery disease and preserved left ventricular function Ischemia Management with Accupril post-bypass graft via inhibition of angiotensin-converting enzyme (IMAGINE) compared with the other major trials in coronary artery disease.
van Gilst WH; Warnica JW; Baillot R; Johnstone D; Calciu CD; Block P; Myers MG; Chocron S; Rouleau JL;
Am Heart J; 2006 Jun; 151(6):1240-6. PubMed ID: 16781228
[TBL] [Abstract][Full Text] [Related]
17. Amelioration by quinapril of myocardial infarction induced by coronary occlusion/reperfusion in a rabbit model of atherosclerosis: possible mechanisms.
Hoshida S; Yamashita N; Kawahara K; Kuzuya T; Hori M
Circulation; 1999 Jan; 99(3):434-40. PubMed ID: 9918532
[TBL] [Abstract][Full Text] [Related]
18. Ischemia Management with Accupril post bypass Graft via Inhibition of angiotensin coNverting enzyme (IMAGINE): a multicentre randomized trial - design and rationale.
Warnica JW; Gilst WV; Baillot R; Johnstone D; Block P; Myers MG; Chocron S; Ave SD; Martineau P; Rouleau JL
Can J Cardiol; 2002 Nov; 18(11):1191-200. PubMed ID: 12464983
[TBL] [Abstract][Full Text] [Related]
19. Quinapril. A reappraisal of its pharmacology and therapeutic efficacy in cardiovascular disorders.
Plosker GL; Sorkin EM
Drugs; 1994 Aug; 48(2):227-52. PubMed ID: 7527326
[TBL] [Abstract][Full Text] [Related]
20. Preservation of cardiac function and energy reserve by the angiotensin-converting enzyme inhibitor quinapril during postmyocardial infarction remodeling in the rat.
Hügel S; Horn M; Remkes H; Dienesch C; Neubauer S
J Cardiovasc Magn Reson; 2001; 3(3):215-25. PubMed ID: 11816618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]